Navigation Links
Liver cancer linked to cellular repair pathway

The unchecked activity of a cell signaling pathway crucial in embryonic development and the liver's response to injury leads to liver cancer, researchers from Duke University Medical Center and John Hopkins University School of Medicine have found.

Because the pathway, called Hedgehog, is present only in immature, stem-like liver cells, the discovery offers hope for targeted treatment of liver cancer, one of the leading causes of cancer-related death in the world. Laboratory experiments show that blocking the Hedgehog pathway kills cancer cells but leaves mature healthy liver cells intact, the researchers report. Treating patients with medications to interrupt the pathway would likely eliminate the cancer cells while sparing healthy liver tissue, said Jason Sicklick, M.D., a postdoctoral fellow at Duke and lead author of the study.

"Currently, there are no good chemotherapies for liver cancer, and many people with advanced liver disease are too ill for surgery to remove tumors," Sicklick said. "There is a desperate need for effective anticancer treatments that are safe for patients with liver disease."

The results will be published in the April 4, 2006, issue of Carcinogenesis. The research was funded by the National Institutes of Health.

Finding the overactivated Hedgehog pathway in liver cancer, but not in mature liver cells, also opens the door for development of new diagnostic tests for the disease, Sicklick said. "Signs of excessive Hedgehog activity in cirrhotic patients could alert us to early stages of liver cancer, as well as provide valuable prognostic information for patients," he said.

Sicklick and colleagues also discovered a new Hedgehog pathway mutation in a patient with liver cancer that may lead to overactivation of Hedgehog and trigger abnormal cell growth, promoting cancer development. In test tube and cell culture experiments, blocking the Hedgehog pathway reduced growth of cancer cells by over 90 percent.'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Research Gives Hope For Liver Damage
2. Gene Therapy Cures Inherited Liver Disease In Rats
3. Liver regeneration may be simpler than previously thought
4. Viral DNA sequence a possible trigger for breast cancer
5. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
6. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
7. Columbia research lifts major hurdle to gene therapy for cancer
8. Combination therapy boosts effectiveness of telomere-directed cancer cell death
9. Mitochondrial DNA mutations play significant role in prostate cancer
10. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
11. BRCA1 causes ovarian cancer through indirect, biochemical route
Post Your Comments:
(Date:12/3/2009)... that staph infections are caused by many bacterial cells that ... called quorum sensing because many bacteria must be present to ... has determined that the very first stage of staph infection, ... occurs in a single cell and that this individual process ...
(Date:12/3/2009)... measured CO2 levels for the past three years in ... area near Valladolid. The results, which are the first ... the levels rose "significantly" between 2002 and 2005. , ... to find out about carbon dioxide (CO2) levels, and ...
(Date:12/2/2009)... Less acculturated Latino men have a more difficult time ... U.S. culture, but acculturation has no affect on Latinas ... published in Cancer Epidemiology, Biomarkers & Prevention , ... The December issue has a special focus on tobacco. ...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 1Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Stroke Damage Is Less in Rats Given Opioids 49194 1
... about what it,s like to be a bat, but for ... aspects of the human brain and nervous system. , Cynthia ... at the University of Maryland, College Park, Md., is one ... the heads of bats. , Her new research suggests there ...
... of Natural Science, or MNS, recently participated in a project ... world. This study the largest study of bird genetics ... evolutionary tree, but completely redrawn it. The results of this ... genetic resources collection, will be published in Science ...
... Research by two Kansas State University scientists could ... oil-rich algae in oceans for biofuel. , K-State,s ... manufacturing systems engineering, and Wenqiao "Wayne" Yuan, assistant ... a $98,560 Small Grant for Exploratory Research from ...
Other Biology News:What it's like to be a bat 2What it's like to be a bat 3'Early bird' project really gets the worm 2Algae from the ocean a sustainable energy source of the future 2
(Date:12/3/2009)... Nikon Corporation, an innovator of advanced optical ... licensing agreement with Harvard University granting Nikon the ... (STORM) technology. Under the terms of the agreement, ... market them with the N-STORM name. ,, ...
(Date:12/3/2009)... 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ... voluntary recall of five lots and voluntary market withdrawal ... Daytrana ® . Shire is taking this action because ... future may not meet their release liner removal specification, ...
(Date:12/3/2009)... Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: ... services for drug discovery and life sciences research, today ... imaging systems. Living Image software drives the more than ... Living Image 4.0 features advanced spectral unmixing tools to ...
(Date:12/2/2009)... Dec. 2 Spectrum Blue Steel is emerging as one ... Through the efforts of True Green Energy Group and True ... been in the recycling business for over 25 years, stated ... and is setting the stage for spectacular earnings because of ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3
... Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today that the company ... Grey, president & chief,executive officer of SGX Pharmaceuticals, will provide ... as follows:, -- 19th Annual Piper Jaffray Health ... 2007 at 11:30 AM Eastern Standard Time at The Pierre ...
... Arpida Ltd,(SWX: ARPN) announced today the results ... between intravenous iclaprim and warfarin.,Warfarin is widely used ... dosing needs to be well-controlled.The drug-drug interaction study,comprised ... Dosing of,warfarin with and without pre- and co-administration ...
... be published Nov. 22 in the online edition of ... researchers reports the genetic reprogramming of human skin cells ... finding is not only a critical scientific accomplishment, but ... stem cell biology as human embryos may no longer ...
Other Biology Technology:SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim 2Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim 3UW-Madison scientists guide human skin cells to embryonic state 2UW-Madison scientists guide human skin cells to embryonic state 3
Sheep polyclonal to Malate Dehydrogenase ( Abpromise for all tested applications). Antigen: Full length protein - Pig heart malate dehydrogenase. Entrez Gene ID: 4190 Swiss Protein ID: P...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Antigen peptide transporter ... TAP2) (Peptide transporter PSF2) ... (PSF-2) (Peptide transporter involved ... [Source:Uniprot/SWISSPROT;Acc:Q03519] ...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Biology Products: